ScholarIQanswers from OpenAlex & ORCID
Mark R. Pittelkow
ResearcherPublications, citations & collaboration network
Mark R. Pittelkow is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Mark R. Pittelkow have?
ScholarIQindexed works
Mark R. Pittelkow has 513 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Mark R. Pittelkow have?
ScholarIQcitation count
Mark R. Pittelkow has 27,562 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Mark R. Pittelkow?
ScholarIQh-index
Mark R. Pittelkow has an h-index of 90 in OpenAlex.
What is the i10-index of Mark R. Pittelkow?
ScholarIQi10-index
Mark R. Pittelkow has an i10-index of 290 in OpenAlex.
What is the ORCID of Mark R. Pittelkow?
ScholarIQorcid
The ORCID for Mark R. Pittelkow is on the source record.
What is the OpenAlex record for Mark R. Pittelkow?
ScholarIQopenalex
The OpenAlex for Mark R. Pittelkow is on the source record.
What are the most-cited papers on Mark R. Pittelkow?
ScholarIQmost cited works
Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)
Elise A. Olsen, Eric C. Vonderheid, Nicola Pimpinelli, Rein Willemze, Youn Kim, Robert Knobler, Herschel Zackheim, Madeleine Duvic, Teresa Estrach, Stanford Lamberg, Gary S. Wood, Reinhard Dummer, Annamari Ranki, Günter Burg, Peter Heald, Mark R. Pittelkow, M.G. Bernengo, Wolfram Sterry, L. Laroche, Franz Trautinger, Sean Whittaker
Clinical End Points and Response Criteria in Mycosis Fungoides and Sézary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer
Elise A. Olsen, Sean Whittaker, Youn H. Kim, Madeleine Duvic, H. Miles Prince, Stuart R. Lessin, Gary S. Wood, Rein Willemze, Marie‐France Demierre, Nicola Pimpinelli, Maria Grazia Bernengo, Pablo L. Ortiz‐Romero, M. Bagot, Teresa Estrach, Joan Guitart, Robert Knobler, José Antônio Sanches, Keiji Iwatsuki, Makoto Sugaya, Reinhard Dummer, Mark R. Pittelkow, Richard T. Hoppe, Sareeta Parker, Larisa J. Geskin, Lauren Pinter‐Brown, Michael Girardi, Günter Burg, Annamari Ranki, Maarten H. Vermeer, Sarah McCue Horwitz, Peter Heald, Steven T. Rosen, Lorenzo Cerroni, Brigette Dréno, Eric C. Vonderheid
Malignant Melanoma in the 21st Century, Part 1: Epidemiology, Risk Factors, Screening, Prevention, and Diagnosis
Svetomir N. Markovic, Lori A. Erickson, Ravi D. Rao, Robert R. McWilliams, Lisa A. Kottschade, Edward T. Creagan, Roger H. Weenig, Jennifer L. Hand, Mark R. Pittelkow, Barbara A. Pockaj, Aditya Bardia, Celine M. Vachon, Steven E. Schild, Susan D. Laman, William J. Maples, José S. Pulido, J. Douglas Cameron
Malignant Melanoma in the 21st Century, Part 1: Epidemiology, Risk Factors, Screening, Prevention, and Diagnosis
Svetomir N. Markovic, Lori A. Erickson, Ravi D. Rao, Robert R. McWilliams, Lisa A. Kottschade, Edward T. Creagan, Roger H. Weenig, Jennifer L. Hand, Mark R. Pittelkow, Barbara A. Pockaj, Aditya Bardia, Celine M. Vachon, Steven E. Schild, Susan D. Laman, William J. Maples, José S. Pulido, J. Douglas Cameron
Survival, Risk Factors, and Effect of Treatment in 101 Patients With Calciphylaxis
James T. McCarthy, Rokea A. el‐Azhary, Michelle T. Patzelt, Amy L. Weaver, Robert C. Albright, Alina D. Bridges, Paul Claus, Mark D.P. Davis, John Dillon, Ziad Zoghby, LaTonya J. Hickson, Rajiv Kumar, Robert D. McBane, Kathleen McCarthy-Fruin, Marian T. McEvoy, Mark R. Pittelkow, David A. Wetter, Amy W. Williams